$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Summary of matters that need to be paid attention to while taking Asnib/Asiminib (Xinbeli)
2026-02-01 22:25:32
Check Details
Ritlecitinib generic drug prices and patient purchasing information
2026-02-01 22:25:32
Check Details
Analysis of drug safety and long-term use risks of sparsentan
2026-02-01 22:25:32
Check Details
How long does it take to stop taking Ixazomib (Enleri) and suggestions for stopping it?
2026-02-01 22:25:32
Check Details
Rubitidine/Rubicatin (Zanbiga) injection every few days and analysis of treatment schedule
2026-02-01 22:25:32
Check Details
Dose adjustment and precautions for using Pimitespib in the elderly
2026-02-01 22:25:32
Check Details
Analysis of the main ingredients and pharmacological effects of afatinib (Gitarel)
2026-02-01 22:25:32
Check Details
Suggested medication time and analysis of the best usage plan for DaliRasheng (Keweike)
2026-02-01 22:25:32
Check Details
Analysis of whether Olaparib has been included in medical insurance and reimbursement policies
2026-02-01 22:25:32
Check Details
How long does it take for the blood count to return to normal after taking venetoclax/venetoclax (venetoclax) and the monitoring plan
2026-02-01 22:25:32
Check Details
Detailed analysis of the targets and mechanisms of action of Asnib/Assiminib
2026-02-01 22:25:32
Check Details
Is ritixitinib (Lefenox) a targeted drug and its mechanism analysis
2026-02-01 22:25:32
Check Details
1
2
...
2202
2203
2204
2205
2206
2207
2208
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma